Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Blanc

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Plos One|April 18, 2012
White matter atrophy and cognitive dysfunctions in neuromyelitis opticaFrederic Blanc, Vincent Noblet, Barbara Jung, et al.
Alzheimer'S Research & Therapy|August 23, 2025
The association between plasma and MRI biomarkers in dementia with lewy bodiesCarmen Peña-Bautista, Katharina Bolsewig, Maria C Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterionGauthier Calais, Gerard Forzy, Charlotte Crinquette, et al.
ISRN Neurology|November 14, 2013
Cognitive Dysfunction and Dementia in Primary Sjögren's SyndromeFrederic Blanc, Nadine Longato, Barbara Jung, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2018
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stageOlivier Bousiges, Stephanie Bombois, Susanna Schraen, et al.
Brain : a Journal of Neurology|July 24, 2009
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 casesPierre Labauge, Laetitia Horzinski, Xavier Ayrignac, et al.
The Oncologist|June 9, 2017
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Jean-Frederic Blanc, Steven Miles, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in TBK1 carriersPaola Caroppo, Agnès Camuzat, Anne De Septenville, et al.
ESMO Open|August 21, 2020
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trialsAndrew X Zhu, Ryan D Nipp, Richard S Finn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 2, 2025
Response to systemic treatments and survival of fibrolamellar carcinomas: An AGEO-SFCE French multicenter retrospective cohortXixi Ye-Tran, Mohamed Bouattour, Brice Fresneau, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Plos One|April 18, 2012
White matter atrophy and cognitive dysfunctions in neuromyelitis opticaFrederic Blanc, Vincent Noblet, Barbara Jung, et al.
Alzheimer'S Research & Therapy|August 23, 2025
The association between plasma and MRI biomarkers in dementia with lewy bodiesCarmen Peña-Bautista, Katharina Bolsewig, Maria C Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterionGauthier Calais, Gerard Forzy, Charlotte Crinquette, et al.
ISRN Neurology|November 14, 2013
Cognitive Dysfunction and Dementia in Primary Sjögren's SyndromeFrederic Blanc, Nadine Longato, Barbara Jung, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2018
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stageOlivier Bousiges, Stephanie Bombois, Susanna Schraen, et al.
Brain : a Journal of Neurology|July 24, 2009
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 casesPierre Labauge, Laetitia Horzinski, Xavier Ayrignac, et al.
The Oncologist|June 9, 2017
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Jean-Frederic Blanc, Steven Miles, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in TBK1 carriersPaola Caroppo, Agnès Camuzat, Anne De Septenville, et al.
ESMO Open|August 21, 2020
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trialsAndrew X Zhu, Ryan D Nipp, Richard S Finn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 2, 2025
Response to systemic treatments and survival of fibrolamellar carcinomas: An AGEO-SFCE French multicenter retrospective cohortXixi Ye-Tran, Mohamed Bouattour, Brice Fresneau, et al.
Pageof 9